The learning perspective of panic disorder distinguishes between acute panic and anxious apprehension as distinct emotional states. Following animal models, these clinical entities reflect different stages of defensive reactivity depending upon the imminence of interoceptive or exteroceptive threat cues. The current study tested this model by investigating the dynamics of defensive reactivity in a large group of patients with panic disorder and agoraphobia (PD/AG).
Patients with panic disorder (PD) experience recurrent unexpected panic attacks and worry about future attacks and their injurious consequences. It has been suggested that these emotional states rapidly beginning brief episodes of intense fear to imminent threat and future oriented anxietytowardthe occurrence of nonpredictable aversive events are not only distinct clinical entities (1) but are also regulated by different neural networks.
Using potentiation of the startle response to measure fear and anxiety, Davis et al. (2) demonstrated in rodents that imminent fear-eliciting stimuli activate the basolateral amygdala, which projects to the central nucleus of the amygdala. The medial part of the central nucleus then serves as the main output relay producing rapid and short-acting fear or panic responses (2) . Additionally, the lateral part of the central nucleus releases corticotropin-releasing hormone into the bed nucleus of the stria terminalis (BNST), eliciting the more slowly acting but longer lasting sustained anxiety response to an unsafe context. Accordingly, lesions of the central nucleus of the amygdala, but not the BNST, blocked fear-potentiated startle to short cues predicting painful shocks. In contrast, lesions of the BNST, but not the central nucleus, blocked potentiated startle in an unsafe context. Interestingly, PD patients do not show increased phasic fear to short cues predicting the occurrence of aversive events (3, 4) but do show stronger potentiation of the startle reflex in an unsafe context of unpredictable shocks (5) . This suggests that patients might be particularly vulnerable to unsecure environments, comparable with the pre-encounter defense described in the predator-imminence model (6, 7) . According to this model, defensive behavior is dynamically organized depending upon the proximity of the threat. At the first stage when the organism is in a context where a predator has been encountered previously but has not yet been detected (pre-encounter defense), preemptive behavior, including threat-nonspecific vigilance, is engaged. As soon as the predator is identified (postencounter), the organism freezes and increased selective attention is allocated to the potential threat. Circa strike defense, characterized by strong autonomic arousal and escape behavior, is activated when the threat is imminent.
This model is in line with several tenants of the learning perspective on the etiology of PD (1, 8) . According to this perspective, initial attacks, defined as a sense of extreme fear of dying or of losing control accompanied by a massive autonomic surge and flight tendencies, a typical circa strike defense behavior, set the stage for the development of PD. By associating exteroceptive and interoceptive cues that are present during the first panic attack with the upcoming danger of further full-blown panic attacks, patients not only become hypervigilant toward somatic symptoms (pre-encounter defense) but also develop anxious apprehension when subtle body symptoms are identified (postencounter defense). Supporting this notion, individuals who report high trait fear of somatic symptoms, i.e., a risk marker for PD, show increased potentiation of their startle response when weak interoceptive cues are identified after recovery from a hyperventilation challenge (9).
In the current study, we tested this theoretical perspective by investigating the dynamics of defensive behavior in a large sample of patients meeting DSM-IV (text revision) criteria of panic disorder and agoraphobia (PD/AG). Agoraphobic fear and avoidance refer to situations where it is difficult to escape and where panic attacks might occur, clustering around situations entailing some degree of entrapment like tunnels, elevators, crowded areas, public transportation, or being in the backseat of a car. Interestingly, such fears of restriction and avoidance of entrapment are also main symptoms of claustrophobia (10) . Indeed, patients with PD/AG regularly show high comorbidity with claustrophobia (11) and also have clinical features in common: both groups fear and try to avoid interoceptive stimuli (12, 13) and suffer from uncued panic attacks (11, 14) . To study the dynamics of defensive reactivity in patients with PD/AG, we used a standardized behavioral avoidance test (BAT) (exposure to a small, dark, and closed chamber) that has successfully been used previously to investigate fear response patterns in claustrophobia (15) . In addition, this BAT is very much comparable with the paradigms used in animal research to study anxious apprehension (e.g., light enhanced startle or open field paradigms), thus enabling translation from animal findings to human clinical anxiety.
To assess defensive reactivity in patients with PD/AG, we measured autonomic arousal (heart rate and skin conductance), flight behavior (as indexed by premature termination of the exposure period), experience of anxious apprehension (measured before the onset of the task), experience of panic during the task (marked by pressing a panic button), and modulation of the startle reflex as an index of amygdala-dependent defense system activation (2, 16) . The modulation of the startle response seems to be a specifically interesting measure in this context because recent evidence suggests that the startle reflex is markedly inhibited during the imminent stage of threat (17) .
We hypothesized that being locked in a confined dark chamber would elicit a range of defensive reactivity varying from anxious apprehension to active escape or complete avoidance in many, but probably not all, patients with PD/AG. Moreover, according to the learning perspective of the etiology of PD (1), anxious apprehension during such challenge should provoke panic attacks. Therefore, we expected that the probability for the occurrence of panic attacks would be increased in this context, providing the opportunity to monitor defensive reactivity during panic attacks. Finally, we expected that during imminent threat, such as an acute panic attack or active flight behavior (i.e., escape from the chamber), autonomic arousal would increase and would be associated with a relative inhibition of the startle reflex, while the same defensive reflex would be potentiated during anxious apprehension.
Methods and Materials

Participants
Three hundred forty-five patients (259 female patients) of an overall total of 369 patients (18) 1 with a principal diagnosis of panic disorder with agoraphobia and enrolled for the multicenter randomized controlled clinical trial study Mechanism of Action in Cognitive Behavioral Therapy (CBT) participated in the study. Patient recruitment and inclusion and exclusion criteria of the overarching clinical trial, as well as patients' sociodemographic characteristics and comorbid diagnoses, are described elsewhere (18, 19) . Diagnosis of PD/AG was established by a standardized computer-administered face-to-face Computer Assisted Personal Interview-World Health Organization-Composite International Diagnostic Interview (CAPI-WHO-CIDI) by trained and certified interviewers (20) (see Supplement 1 for reliability of the diagnosis). Mean age of the patients at assessment was 35.26 years, SD = 10.71. All patients were Caucasian and free from psychotropic medication. Patients gave written informed consent after receiving a detailed description of the study. The study was approved by the Ethics Committee of the Medical Faculty of the Technical University of Dresden, which was valid for all participating centers.
Experimental Stimuli and Procedure
Following inclusion of the patients, severity of psychopathology was evaluated during baseline assessment using several questionnaires (18) . Patients participated in the BAT in each of the eight participating centers 2 following baseline assessment and before treatment. The BAT consisted of a standardized exposure to a small (75 cm wide, 120 cm long, 190 cm high), dark and closed test chamber constructed according to the descriptions by Öst et al. (15) . All assessment personnel were trained to adhere to a written study manual. After explaining the procedure and attaching the sensors for recording of the physiological signals, the BAT commenced with an anticipation period, during which patients were facing the test chamber with its door open while sitting for 10 minutes. Then, patients were instructed to enter the test chamber and take a seat and the door was locked from outside by the experimenter. Patients were instructed to sit quietly in the chamber for as long as possible and to knock on the door if they wanted to leave the chamber before the maximum time elapsed (10 minutes; see Supplement 1 for exact instruction). All patients complied with these instructions as documented by the assessors. After exposure, patients were again seated in front of the opened chamber for an 8-minute recovery period. Patients were unaware of the maximum duration of each period. Intensity of experienced anxiety and panic symptoms were assessed by paper and pencil immediately after each period on a 10-point Likert scale ranging from 1 (not at all) to 10 (very strong). Patients were instructed to press a button whenever they experienced a panic attack. The output of the button press was digitized by an analog to digital (A/D) converter (Scientific Solutions, Mentor, Ohio) and recorded as a separate channel with the VPM software (21) .
A digitized 50-msec burst of white noise (105 dBA, rise/fall time <1 msec) generated by the sound tool box of VPM was amplified by a recording mixer (Omintronic RS-602, Waldbüttelbrunn, Germany) and presented binaurally through headphones (AKG K66, Vienna, Austria) to serve as startle-eliciting stimulus. A continuous 60 dBA background noise was generated by the recording mixer. Thirty acoustic startle probes were presented (three probes per minute with a randomized interstimulus interval (varying between 10 sec and 30 sec) during anticipation and exposure. Nine startle probes were presented during the last 3 minutes of the recovery period.
Experimental Control and Data Collection
A personal computer running VPM (22) controlled stimulus presentation and data acquisition. Bioamplifiers recorded electromyographic activity over the orbicularis oculi, skin conductance level (SCL), and electrocardiogram as reported elsewhere (23) .
Data Reduction and Analysis
The reflex eyeblink data were reduced and scored offline using a computer program that identified the peak amplitude (in microvolts; for details of the scoring procedure, see Limberg et al. [23] and Supplement 1).
Skin conductance level (in μS) and electrocardiogram R-R intervals (converted to beats per minute) were reduced into half-second bins and averaged across blocks of 10 seconds, excluding the 7 seconds after delivery of the startle probes.
As will be elaborated below, patients were grouped according to their defensive behavior in the BAT or lack thereof into anxious completers, escapers, avoiders, or nonanxious completers. To evaluate potential differences between these groups, univariate analyses of variance with group as a between-subjects variable and phase (anticipation vs. exposure vs. recovery) (and in the case of physiological data, time [ten 1-minute blocks]) as within-subject variables were conducted for all dependent variables. All statistical tests used a significance level of p < .05. Greenhouse-Geisser corrections of degrees of freedom were applied whenever appropriate.
Results
Behavioral Data
Thirty-nine patients (11.3%) refused to participate in the BAT entirely or refused to enter the chamber after the anticipation period and were therefore classified as avoiders. Seventy-two patients (20.9%) entered the test chamber after completion of the anticipation period but did not finish the exposure and were therefore classified as escapers. The exposure duration in this group varied between 3 and 580 seconds (mean = 225.64; SD = 170.96). Two hundred thirty-four patients remained in the test chamber for the entire 10 minutes of the exposure period and were classified as completers. Within this group, 109 patients (31.6%) reported only minimal or no anxiety during the exposure (anxiety ratings ≤ 3); thus, these patients served as a nonanxious control group (nonanxious completers) because the BAT was obviously not a challenge for these patients. One hundred twenty-five patients (36.2%) completed the exposure test despite medium to high levels of anxiety (anxious completers). Table 1 shows the gender distribution, age, and severity of PD/AG, depressive, and claustrophobic symptoms. Gender distribution differed significantly between groups with a higher proportion of female patients in the avoider and escaper compared with both completer groups. Moreover, compared with the nonanxious completers, all other patients were characterized by significantly more severe panic/anxiety and depressive symptoms both according to clinical interview and self-report data. Avoiders and escapers reported significantly more claustrophobic fear than anxious completers who reported significantly higher claustrophobic fear than nonanxious completers.
Anticipation Period
During anticipation, avoiders, escapers, and anxious completers reported more anxiety and more intense panic and showed higher heart rates (HR) and SCL than nonanxious completers. No significant group differences occurred for startle response magnitudes. Means, SD, and significant group differences in reported anxiety and defensive reactivity for the four groups during anticipation, exposure, and recovery are presented in Table 2 
Exposure Period
Anxious Versus Nonanxious Completers. Exposure resulted in a significant increase in intensity of reported anxiety and panic symptoms in anxious completers but not in nonanxious completers [ Table 2 ; mean differences between anticipation and exposure: anxious completers: Δ = 1.89 and 1.03 for reported anxiety and intensity of symptoms, respectively; nonanxious completers: Δ = .06 and .07; phase × group Fs(1,232) = 75.42, 66.60; η = .09, .09; both ps < .001, for reported anxiety and panic symptoms, respectively; Table 2 ]. Increase in HR from the last minute of anticipation to the first minute of exposure was also significantly greater for escapers compared with anxious completers [time × group F(1,146) = 6.84, p < .01, η 2 = .05; Figure 1 ], supporting the selfreport data. 4 In contrast, no significant differences between both groups were observed for startle potentiation [time × group F(1,107) = 1, η 2 = .01]. There was, however, a significant inverse relationship between HR increase and startle potentiation in escapers, r = -.39; p < .05, 5 but not in anxious completers, r = -.13, p = .32, and nonanxious completers r = -.02, p = .32. Following up on this finding, we analyzed the physiological responses 1 minute before the escape. Heart rate, as well as SCL, significantly increased during the last 60 seconds before escape [time Fs Circa Strike: Panic Attacks. Twenty-six patients reported 34 panic attacks (range: 1-3) during exposure by pressing the panic button, enabling an event-related second by second analysis of physiology before and during the indicated panic attacks. 7 Panic attacks were only 3 For the escapers, ratings were obtained immediately after they left the dark chamber. 4 From the group of 72 escapers, 17 patients left the dark room within the first minute, leaving only 55 patients who provided a complete dataset for the analysis of the physiological responses. Escapers who left the chamber within the first minute tended to show higher increases in HR (Δ beats per minute = 16.55) than escapers who remained in the dark room for at least 1 minute (Δ beats per minute = 9.35), while there were no significant differences in the other variables, supporting the findings for the group comparisons including escapers with a complete dataset. 5 When blink magnitudes were converted to T scores controlling for interindividual variability that was unrelated to the experimental condition, this inverse relationship between startle potentiation and HR increase was even more pronounced (r = -.56, p < .01). 6 Of the entire group of 72 escapers, only 26 patients could be included into these analyses because only these patients remained in the dark room for at least 120 seconds and provided reliable electrocardiogram, electrodermal activity, and electromyogram data during the last 60 seconds. 7 Patients were only included if they received a current primary diagnosis of panic disorder and agoraphobia (as defined by the criteria of the DSM-IV [text revision]). All patients had to report recurrent panic attacks defined as discrete episodes of intense fear accompanied by at least four symptoms with the peak in severity within 10 minutes and concerns about the consequences of these attacks. Thus, all patients were familiar with the defining observed in escapers (16 attacks) and anxious completers (18 attacks; for comparison of these groups, see Supplement 1) but not in the nonanxious completers. Panic attacks were characterized by a significant increase in HR and SCL [time Fs(18,180) = 2.06, 2.74; η 2 = .17, .22; both ps < .01 for HR and SCL, respectively; Figure 3A ]. 8 Interestingly, the significant increase in HR already started 20 seconds before the button press [from -30 to 0 sec: time F(6,60) = 2.48, p < .05, η 2 = .21], suggesting that the perceived increase in HR might have triggered the button press. Again, blink magnitudes showed an opposite response pattern. Figure 3B depicts the HR changes and blink responses of those 11 panic attacks for whom data from both variables were complete.
Recovery Period
Results are reported in Supplement 1.
Discussion
The current study investigated defensive reactivity during exposure to a small, dark chamber in a large group of PD/AG patients. The selection of this highly standardized BAT was guided by the hypothesis that fears of restriction and suffocation are not only hallmark symptoms in claustrophobic patients (10) but are also prominent symptoms in patients with PD/AG (12) . In fact, this BAT clearly elicited strong defensive reactivity as indexed by self-reported distress, physiological arousal, 9 and fear-potentiated startle in over two thirds of the patients. Since this behavioral task did not require any motor acts that would affect physiological respon substantially (like in the early behavioral walk paradigms [24, 25] ), it proved to be a highly useful tool to assess the dynamics of defensive reactivity in the majority of PD/AG patients. We found evidence that defensive reactivity of these patients was organized in a comparable way as described for animals in the predator-imminence model (26) . With increasing intensity of bodily symptoms, i.e., increasing imminence of interoceptive threat, defensive reactivity switches from anxious apprehension to circa strike defense.
ses
Defensive Reactivity During Anxious Apprehension
Patients who reported elevated anxiety and more symptoms during the BAT and completed the task showed a significant increase in HR and SCL, indicating augmented sympathetic arousal that was maintained during the entire exposure period indicating sustained anxious apprehension in this patient group. Accordingly, startle response magnitudes were also potentiated. While darkness seems to be a potentially threatening context also for nonanxious individuals (replicating previous findings [4, 27] , startle responses were also facilitated during characteristics of a panic attack. Furthermore, all patients reporting a panic attack during the BAT reported intense fear (mean score: 9.04, SD = .92) and between 6 and 13 somatic and cognitive symptoms (mean score: 9.77, SD = 2.25) with moderate mean intensity (mean score: 5.65, SD = 1.70) after they left the chamber.exposure to darkness in nonanxious patients), startle potentiation was significantly stronger for those patients who also showed elevated sympathetic arousal and reported more anxiety. Similar to increased physiological arousal, fear-potentiated startle did not habituate but was rather maintained over the entire exposure period, similar to the sustained potentiation of the startle reflex that can be observed in animals during an unsafe context in which painful stimuli could occur (2) .
Defensive Reactivity During Active Escape
Startle modulation changed substantially when defensive behavior changed from anxious apprehension into an active flight response. Seventy-two patients actively escaped from the chamber. While 17 patients fled from the chamber within the first minute, 55 patients stayed long enough to obtain reliable measures of defensive reactivity 1 minute before the flight response. Autonomic arousal increased linearly 1 minute before active escape behavior initiated at the peak of the autonomic surge, supporting the hypothesis that this strong increase in somatic symptoms was an imminent threat for these patients. In contrast, startle responses were inversely correlated with HR increases during early exposure and were relatively inhibited during the autonomic surge before escape when compared with the anxious apprehension at the beginning of the exposure period. These data are in line with the results by Löw et al. (17) who showed that increases in HR and SCL were accompanied by a relative inhibition of the startle reflex immediately before fear-related action responses in healthy volunteers. These data are also in line with the predator-imminence model (26, 28, 29) . When a remote threat is encountered (anxious apprehension), the organism becomes hypervigilant and ventrolateral columns of the periaqueductal gray (PAG) evoke behavioral adjustments like freezing to support the attentive scanning of the potentially dangerous context. Under these circumstances, defensive reflexes like the startle responses are potentiated (30). When the threat becomes more imminent, the dorsolateral PAG becomes dominant, controlling active defensive behavior like flight or fight. Using an artificial intelligence predator model to study the dynamics of defensive reactivity in humans, Mobbs et al. (31, 32) found that postencounter defense preferentially activated the ventromedial prefrontal cortex, subgenual anterior cingulate cortex, amygdala, hippocampus, and hypothalamus, while circa strike engaged the PAG and the dorsal anterior cingulate cortex, which is also involved in analgesia (33) . The inhibition of the startle response observed immediately before escape is in accordance with these results, suggesting that-parallel to analgesia-protective reflexes are also inhibited during active escape. A possible mechanism for this inhibition is that processing of external cues might be reduced during circa strike to facilitate escape. Recent findings observing more errors in a secondary task during panic attacks (32) would also support this interpretation and would suggest that acute panic attacks can be conceptualized as circa-strike defense.
Defensive Reactivity During Acute Panic Attacks In the current study, we recorded 34 panic attacks in real time during the exposure to the dark room. Paralleling the response pattern immediately before escape, panic attacks were also characterized by strong increases in HR and SCL. Again, in contrast to the increase in autonomic arousal, startle blink magnitudes were relatively inhibited during the acute panic attack compared with the startle responses elicited before the panic attacks. These data support a learning theory perspective of the etiology of PD, suggesting that acute panic attacks and anxious apprehension are distinct emotional phenomena (1, 8) . The defensive response pattern observed during an acute panic attack resembles the pattern of activity that was observed immediately before escape, suggesting that the panic attack could be considered as a typical circa-strike defense probably linked to the activation of the dorsal PAG. Animal data show that chemical stimulation of the dorsolateral PAG in rodents elicits panic-like behavior (like vigorous running [34] ). Indeed, several patients escaped from the chamber at the peak of their panic attack.
In line with findings from an ambulatory monitoring study of spontaneous panic attacks (35) , increase in HR but also SCL started before patients pressed the panic button, suggesting that the increase in autonomic arousal indeed triggered the subjective experience of the panic attack. These data are also in line with the learning perspective of PD, stating that weak and early physical panic symptoms are associated with full-blown panic attacks and thus can serve as conditioned stimuli triggering future panic attacks. Besides these interoceptive cues, exteroceptive stimuli might have also contributed to the onset of the panic attacks, particularly because only patients with PD/AG were included in the study. The autonomic surge decreased already after 1 minute, thus supporting earlier observations (36,37) monitoring panic attacks in individual cases and finding that even strong panic attacks subside within about 5 minutes.
Limitations
Despite the overall large sample size, analyses of specific physiological response patterns during circa-strike defense had to be restricted to those patients for whom a complete dataset across all physiological measures was available. This resulted in a quite substantial loss of data. Therefore, the current findings need to be replicated in future research with larger sample sizes. Moreover, while we had continuous measures of physiological reactivity, we did not continuously record verbal report of anxious apprehension. Therefore, we cannot rule out that the reported feeling of anxious apprehension might have increased before or in parallel to the increase in the autonomic measures. Future research should continuously assess these verbal report data to further clarify the associations between the different response systems during the defense cascade.
Summary
Although all patients of the current sample received the principal diagnosis of PD/AG, defensive reactivity in the standardized BAT differed quite substantially between these patients. Defensive reactions ranged from anxious apprehension to circa-strike defense. Moreover, 39 patients refused to enter the dark chamber. These avoiders were clinically more severely impaired and scored higher on the Beck Depression Inventory than the nonanxious completers but did not differ significantly in these variables from the escapers. However, 58.9% of the avoiders had three or more comorbid diagnoses compared with 42.5% of the escapers, suggesting that these patients exhibit more severe psychopathology. These data confirm recent evidence from McTeague et al. (38) who found clear differences in defensive reactivity between PD/AG patients depending upon general symptom severity. Whether different genetic dispositions also contribute to these differences in defensive reactivity is an open question that needs to be evaluated in future research. Moreover, future research has to elucidate whether differences in defensive reactivity of PD/AG patients could be used to predict treatment outcome. 
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